Iatrica Overview
- Founded
-
2007

- Status
-
Private
- Employees
-
3

- Latest Deal Type
-
Accelerator/Inc
- Investors
-
1
Iatrica General Information
Description
Developer of immunoconjugates for cancer therapy.The company operates as a biotechnology company which develops immunoconjugates for the treatment of cancer and other infectious disorders.
Contact Information
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
- 855 North . Wolfe Street
- Suite 613
- Baltimore, MD 21205
- United States
+1 (410) 000-0000
Iatrica Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
1. Accelerator/Incubator | Completed | Generating Revenue |
Iatrica Executive Team (2)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Rajani Ravi Ph.D | Co-Founder | ||
Atul Bedi MD | Co-Founder & President |
Iatrica Signals
Iatrica Investors (1)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Johns Hopkins Technology Ventures | Accelerator/Incubator | 000 0000 | 000000 0 |